Has Nicholas Hornstein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,431 in general payments to Nicholas Hornstein, MD across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Hornstein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Hornstein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Hornstein, MD

Internal Medicine · Houston, TXNPI 1548764848

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,303 of the $25,431 with a category attached, or 83.8%. 17 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 32.5% of the total. 2025 is the largest year on record at $24,397, more than ten times the $147 reported in 2022. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,431in general payments, 2019–2025

Across 43 payments — averaging $591.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$8K
Boston Scientific$6K
Incyte Corporation$5K
Histosonics, Inc.$5K
Intera Oncology, Inc$584
Rigel Pharmaceuticals, Inc.$256
plus $806 from 11 others

$144,550in research payments, 2019–2025

Across 3 payments — averaging $48,183 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Histosonics, Inc.$133K
AbbVie$12K

What the payments were for

Consulting fees$21,30384%
Travel & lodging$2,48110%
Food & beverage$1,3875%
Education$2601%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	6	$8,267
Boston Scientific	2	$5,713
Incyte Corporation	10	$4,955
Histosonics, Inc.	3	$4,850
Intera Oncology, Inc	2	$584
Rigel Pharmaceuticals, Inc.	2	$256
Lilly USA, LLC	2	$184
Ipsen Biopharmaceuticals, Inc	2	$134
Caris MPI, Inc.	1	$121
Amgen	1	$81
Pfizer	3	$76
Bristol Myers Squibb	3	$55
Johnson & Johnson	2	$48
Genentech USA, Inc.	1	$46
AstraZeneca	1	$29
Merck	1	$18
Seagen Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,431 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$13,885

Medicare patients

Services billed

108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Houston

Hussein TawbiHouston$365K
Hans LeeHouston$327K
Tapan KadiaHouston$311K
Nitin JainHouston$281K
Krina PatelHouston$255K
Nicholas ShortHouston$247K
Naveen PemmarajuHouston$230K
Mariana Chavez MacgregorHouston$188K
Shumei KatoHouston$180K
Sukhdeep BasraHouston$168K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →